Cargando…

Prevalence of Anti-PF4 Antibodies After First and Second ChAdOx1 nCoV-19 Vaccinations in Women With Adverse Events: A Brief Report and Literature Review

Detalles Bibliográficos
Autores principales: Choe, Kye Won, Lim, Yong Kwan, Kweon, Oh Joo, Lee, Mi-Kyung, Chung, Jin-Won, Kim, Hye Ryoun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Society for Laboratory Medicine 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9791014/
https://www.ncbi.nlm.nih.gov/pubmed/36544343
http://dx.doi.org/10.3343/alm.2023.43.3.299
_version_ 1784859305818718208
author Choe, Kye Won
Lim, Yong Kwan
Kweon, Oh Joo
Lee, Mi-Kyung
Chung, Jin-Won
Kim, Hye Ryoun
author_facet Choe, Kye Won
Lim, Yong Kwan
Kweon, Oh Joo
Lee, Mi-Kyung
Chung, Jin-Won
Kim, Hye Ryoun
author_sort Choe, Kye Won
collection PubMed
description
format Online
Article
Text
id pubmed-9791014
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Korean Society for Laboratory Medicine
record_format MEDLINE/PubMed
spelling pubmed-97910142023-01-06 Prevalence of Anti-PF4 Antibodies After First and Second ChAdOx1 nCoV-19 Vaccinations in Women With Adverse Events: A Brief Report and Literature Review Choe, Kye Won Lim, Yong Kwan Kweon, Oh Joo Lee, Mi-Kyung Chung, Jin-Won Kim, Hye Ryoun Ann Lab Med Letter to the Editor Korean Society for Laboratory Medicine 2023-05-01 2022-12-22 /pmc/articles/PMC9791014/ /pubmed/36544343 http://dx.doi.org/10.3343/alm.2023.43.3.299 Text en © Korean Society for Laboratory Medicine https://creativecommons.org/licenses/by-nc/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0 (https://creativecommons.org/licenses/by-nc/4.0/) ) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Letter to the Editor
Choe, Kye Won
Lim, Yong Kwan
Kweon, Oh Joo
Lee, Mi-Kyung
Chung, Jin-Won
Kim, Hye Ryoun
Prevalence of Anti-PF4 Antibodies After First and Second ChAdOx1 nCoV-19 Vaccinations in Women With Adverse Events: A Brief Report and Literature Review
title Prevalence of Anti-PF4 Antibodies After First and Second ChAdOx1 nCoV-19 Vaccinations in Women With Adverse Events: A Brief Report and Literature Review
title_full Prevalence of Anti-PF4 Antibodies After First and Second ChAdOx1 nCoV-19 Vaccinations in Women With Adverse Events: A Brief Report and Literature Review
title_fullStr Prevalence of Anti-PF4 Antibodies After First and Second ChAdOx1 nCoV-19 Vaccinations in Women With Adverse Events: A Brief Report and Literature Review
title_full_unstemmed Prevalence of Anti-PF4 Antibodies After First and Second ChAdOx1 nCoV-19 Vaccinations in Women With Adverse Events: A Brief Report and Literature Review
title_short Prevalence of Anti-PF4 Antibodies After First and Second ChAdOx1 nCoV-19 Vaccinations in Women With Adverse Events: A Brief Report and Literature Review
title_sort prevalence of anti-pf4 antibodies after first and second chadox1 ncov-19 vaccinations in women with adverse events: a brief report and literature review
topic Letter to the Editor
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9791014/
https://www.ncbi.nlm.nih.gov/pubmed/36544343
http://dx.doi.org/10.3343/alm.2023.43.3.299
work_keys_str_mv AT choekyewon prevalenceofantipf4antibodiesafterfirstandsecondchadox1ncov19vaccinationsinwomenwithadverseeventsabriefreportandliteraturereview
AT limyongkwan prevalenceofantipf4antibodiesafterfirstandsecondchadox1ncov19vaccinationsinwomenwithadverseeventsabriefreportandliteraturereview
AT kweonohjoo prevalenceofantipf4antibodiesafterfirstandsecondchadox1ncov19vaccinationsinwomenwithadverseeventsabriefreportandliteraturereview
AT leemikyung prevalenceofantipf4antibodiesafterfirstandsecondchadox1ncov19vaccinationsinwomenwithadverseeventsabriefreportandliteraturereview
AT chungjinwon prevalenceofantipf4antibodiesafterfirstandsecondchadox1ncov19vaccinationsinwomenwithadverseeventsabriefreportandliteraturereview
AT kimhyeryoun prevalenceofantipf4antibodiesafterfirstandsecondchadox1ncov19vaccinationsinwomenwithadverseeventsabriefreportandliteraturereview